MedPath

SANDOZ OLANZAPINE

SANDOZ OLANZAPINE

Approved
DIN Number

02310341

Drug Class

Human

Market Date

Dec 6, 2009

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02310341
AIG Number0128783001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AH03 OLANZAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

OLANZAPINEActive
Strength: 2.5 MG
Monograph: OLANZAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.